Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest Richard D. BoycePatrick B. RyanMichel Dumontier Current Opinion Open access 02 July 2014 Pages: 557 - 567
Advancing the Field of Pharmaceutical Risk Minimization Through Application of Implementation Science Best Practices Meredith Y. SmithElaine Morrato Current Opinion Open access 09 July 2014 Pages: 569 - 580
A Comparison of Active Adverse Event Surveillance Systems Worldwide Yu-Lin HuangJinhee MoonJodi B. Segal Review Article Open access 15 July 2014 Pages: 581 - 596
Benefit-Risk Assessment of Orlistat in the Treatment of Obesity Priya SumithranJoseph Proietto Review Article 27 July 2014 Pages: 597 - 608
Identification of Suicide-Related Events Through Network Analysis of Adverse Event Reports Alwis NazirTakashi IchinomiyaYasutomi Kinosada Original Research Article 03 July 2014 Pages: 609 - 616
Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank Ola CasterKristina JuhlinG. Niklas Norén Original Research Article Open access 23 July 2014 Pages: 617 - 628
Undesirable Effects Related to Oral Antineoplastic Drugs: Comparison Between Patients’ Internet Narratives and a National Pharmacovigilance Database Arnaud PagesEmmanuelle Bondon-GuittonHaleh Bagheri Original Research Article 16 July 2014 Pages: 629 - 637
Indicators of Drug-Seeking Aberrant Behaviours: The Feasibility of Use in Observational Post-Marketing Cohort Studies for Risk Management Deborah LaytonVicki OsborneSaad A. W. Shakir Original Research Article Open access 27 June 2014 Pages: 639 - 650
Comment on: “Pharmacovigilance in the Middle East” Yaser Mohammed Al-Worafi Letter to the Editor 02 July 2014 Pages: 651 - 652
Erratum to: Association of Statin Use with Sleep Disturbances: Data Mining of a Spontaneous Reporting Database and a Prescription Database Mitsutaka TakadaMai FujimotoKouichi Hosomi Erratum 03 July 2014 Pages: 653 - 653